Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (461-470 of 487) with videos related to

Pageof 49
Sort By:
Cancer|April 15, 2021
Germline mutations and age at onset of lung adenocarcinomaKaren L Reckamp, Carolyn E Behrendt, Thomas P Slavin, et al.
Cancer Biology & Therapy|May 6, 2011
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinomaDaniel V T Catenacci, Gustavo Cervantes, Soheil Yala, et al.
Journal of Clinical Bioinformatics|May 24, 2011
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology databaseMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2021
The Association between Polluted Neighborhoods and <i>TP53</i>-Mutated Non-Small Cell Lung CancerLoretta Erhunmwunsee, Sam E Wing, Jenny Shen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2019
Pathologic Considerations and Standardization in Mesothelioma Clinical TrialsMing-Sound Tsao, Michele Carbone, Francoise Galateau-Salle, et al.
Journal of Clinical Medicine|October 14, 2022
Addressing Drug Resistance in Cancer: A Team Medicine ApproachPrakash Kulkarni, Atish Mohanty, Supriyo Bhattacharya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.
The New England Journal of Medicine|September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Journal of Clinical Medicine|January 12, 2021
Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope ExperienceLinda D Bosserman, Mary Cianfrocca, Bertram Yuh, et al.
Cancers|July 2, 2021
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer PatientsMoom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Pageof 49

Showing results (461-470 of 487) with videos related to

Sort By:
Pageof 49
Cancer|April 15, 2021
Germline mutations and age at onset of lung adenocarcinomaKaren L Reckamp, Carolyn E Behrendt, Thomas P Slavin, et al.
Cancer Biology & Therapy|May 6, 2011
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinomaDaniel V T Catenacci, Gustavo Cervantes, Soheil Yala, et al.
Journal of Clinical Bioinformatics|May 24, 2011
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology databaseMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2021
The Association between Polluted Neighborhoods and <i>TP53</i>-Mutated Non-Small Cell Lung CancerLoretta Erhunmwunsee, Sam E Wing, Jenny Shen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2019
Pathologic Considerations and Standardization in Mesothelioma Clinical TrialsMing-Sound Tsao, Michele Carbone, Francoise Galateau-Salle, et al.
Journal of Clinical Medicine|October 14, 2022
Addressing Drug Resistance in Cancer: A Team Medicine ApproachPrakash Kulkarni, Atish Mohanty, Supriyo Bhattacharya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.
The New England Journal of Medicine|September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Journal of Clinical Medicine|January 12, 2021
Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope ExperienceLinda D Bosserman, Mary Cianfrocca, Bertram Yuh, et al.
Cancers|July 2, 2021
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer PatientsMoom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Pageof 49